China Medical Technologies Gets China OK for EGFR Assay | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – China Medical Technologies today said that it has received regulatory approval from Chinese authorities to market its real-time PCR-based Epidermal Growth Factor Receptor assay as an aid in making treatment decisions for lung cancer patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.